{"id":559631,"date":"2026-06-12T08:00:00","date_gmt":"2026-06-12T06:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/inhibiteurs-oraux-hautement-selectifs-de-la-tyk-en-phase-iii\/"},"modified":"2026-06-18T17:17:01","modified_gmt":"2026-06-18T15:17:01","slug":"inhibiteurs-oraux-hautement-selectifs-de-la-tyk-en-phase-iii","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/inhibiteurs-oraux-hautement-selectifs-de-la-tyk-en-phase-iii\/","title":{"rendered":"Inhibiteurs oraux hautement s\u00e9lectifs de la TYK en phase III"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>L&#8217;envudeucitinib et le zasocitinib sont des inhibiteurs allost\u00e9riques oraux de la tyrosine kinase 2 (TYK2) qui font actuellement l&#8217;objet d&#8217;essais cliniques dans le traitement du psoriasis en plaques. Les r\u00e9sultats interm\u00e9diaires pr\u00e9sent\u00e9s lors des sessions \u00ab Late-Breaking Research \u00bb du congr\u00e8s annuel de <em>l\u2019American Academy of Dermatology<\/em> (AAD) de cette ann\u00e9e retiennent l\u2019attention. Il convient \u00e9galement de souligner leur profil de s\u00e9curit\u00e9 favorable, ce qui, associ\u00e9 \u00e0 la voie d&#8217;administration par voie orale, constitue un atout majeur en termes de commodit\u00e9.    <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Finhibiteurs-oraux-hautement-selectifs-de-la-tyk-en-phase-iii%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>L&#8217;envudeucitinib et le zasocitinib sont des inhibiteurs allost\u00e9riques oraux de la tyrosine kinase 2 (TYK2) qui font actuellement l&#8217;objet d&#8217;essais cliniques dans le traitement du psoriasis en plaques. Les r\u00e9sultats&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Finhibiteurs-oraux-hautement-selectifs-de-la-tyk-en-phase-iii%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":559638,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Recherche sur le psoriasis : quels sont les projets en cours ?  ","footnotes":""},"category":[11549,11349,11362,11527,11464,11535,11505],"tags":[21744,95013,95017,95014,95021,95018,95015,95016,14035,95019,95020],"powerkit_post_featured":[],"class_list":["post-559631","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-allergologie-et-immunologie-clinique","category-dermatologie-et-venerologie","category-etudes","category-pharmacologie-et-toxicologie","category-rapports-de-congres","category-rhumatologie","tag-aad-fr","tag-academie-americaine-de-dermatologie","tag-envudeucitinib","tag-inhibiteurs-de-la-tyk","tag-latitude-3002","tag-latitude-pso-3001","tag-pipeline","tag-produits-prets-a-consommer","tag-psoriasis-fr-2","tag-resultats-intermediaires","tag-zasocitinib","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-20 12:32:14","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":559641,"slug":"inibitori-orali-altamente-selettivi-della-tyk-in-fase-iii","post_title":"Inibitori orali altamente selettivi della TYK in fase III","href":"https:\/\/medizinonline.com\/it\/inibitori-orali-altamente-selettivi-della-tyk-in-fase-iii\/"},"pt_PT":{"locale":"pt_PT","id":559647,"slug":"inibidores-orais-altamente-seletivos-da-tyk-em-fase-iii","post_title":"Inibidores orais altamente seletivos da TYK em fase III","href":"https:\/\/medizinonline.com\/pt-pt\/inibidores-orais-altamente-seletivos-da-tyk-em-fase-iii\/"},"es_ES":{"locale":"es_ES","id":559650,"slug":"inhibidores-orales-de-tyk-altamente-selectivos-en-fase-iii","post_title":"Inhibidores orales de TYK altamente selectivos en fase III","href":"https:\/\/medizinonline.com\/es\/inhibidores-orales-de-tyk-altamente-selectivos-en-fase-iii\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/559631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=559631"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/559631\/revisions"}],"predecessor-version":[{"id":559639,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/559631\/revisions\/559639"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/559638"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=559631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=559631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=559631"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=559631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}